Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Completed

Conditions studied: Cryopyrin-associated Periodic Syndromes (CAPS), Familial Cold Autoinflam Syn (FCAS), Muckle-wells Syn (MWS), Neonatal Onset Multisystem Inflam Disease (NOMID)

In brief

The purpose of this observational study is to collect additional information regarding long-term safety and effectiveness of Ilaris in the treatment of CAPS patients in clinical practice.

Key facts

Study ID

NCT01213641

Run by

Novartis Pharmaceuticals

People needed

288

Starts

2009-11-01

Expected to finish

2015-12-01

Last updated by the study team

2016-03-28

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients receiving Ilaris (canakinumab) at the time of enrollment as part of medical care

You may not qualify if…

• Local regulations in some locations may exclude patients who receive Ilaris for a non-approved indication
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Little Rock Allergy and Asthma Clinic — Little Rock, Arizona, United States
• Allergy Center at Brookstone — Columbus, Georgia, United States
• Rush Presbyterian - St. Lukes Medical Center — Chicago, Illinois, United States
• Novartis Investigative site — Bregenz, Austria
• Novartis Investigative site — Vienna, Austria
• Novartis Investigative site — Dresden, Germany
• Novartis Investigative site — Hamburg, Germany
• Novartis Investigative site — Heidelberg, Germany
• Novartis Investigative site — Herne, Germany
• Novartis Investigative site — Kiel, Germany
• Novartis Investigative site — Schweinfurt, Germany
• Novartis Investigative site — Tübingen, Germany
• Novartis Investigative site — Oslo, Norway
• Novartis Investigative site — Aarau, Switzerland
• Novartis Investigative site — Basel, Switzerland
• Novartis Investigative site — Geneva, Switzerland
• Novartis Investigative site — Lausanne, Switzerland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.